Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil PCA after lumbar spine surgery
ChiCTR2600120722Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University,Xijing Hospital,;Air Force Medical University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in Spondylopathy (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University,Xijing Hospital,;Air Force Medical University. Primary endpoint: Proportion of patients achieving GI-3 within 24 hours postoperatively. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
Spondylopathy
Beyond the preview
Go deeper on ChiCTR2600120722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120722.